Drug Research

London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...

A New Era of Biopharma Production with AI The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to revolutionise production processes.  Manufacturers are currently facing the most significant challenge in history: the...

The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug discovery is not just a fad but a paradigm shift transforming the way new...

According to a recent analysis released by MarketsandMarkets, the injectable medication delivery market is expected to grow at a compound annual growth rate (CAGR) of about 9% between 2024 and 2029. By 2029, this market is projected to be worth...

Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked deeper biological insights. By integrating structure prediction, molecular modeling,...

When it comes to the pharmaceutical sector, choosing the correct contract development and manufacturing organization (CDMO) is essential to having a successful trip through the process of making a pharmaceutical product. This choice is dependent on two crucial aspects:...

By the year 2025, it is projected that the worldwide expenditure on pharmaceuticals would amount to around $1,742 billion, according to the most recent market studies. While this is happening, it is expected that the total amount of money...